Nutrien Ltd. (NTR) Stock: Price, Forecast & Analyst Target
Nutrien Ltd. (NTR) — MoonshotScore 70/100 (Strong band), calculated Nov 18, 2026. Price $63.84 (-2.40%), as of the Nov 20, 2026 trading session; market cap $30.3B.
Educational signal · not a buy or sell recommendation · How to read this
Nutrien Ltd. · NTR · NYSE · Basic Materials · Agricultural Inputs
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered): Nutrien links fertilizer production in potash, nitrogen, phosphate and sulfate with a broad farm-retail network selling crop nutrients, protection products, seed, merchandise and financial solutions. The key question is whether stronger fertilizer economics and disciplined operations can sustain cash generation when crop-nutrient volumes weaken and operating cash flow swings sharply between reporting periods.
Price as of Nov 20, 2026
Key Statistics
MoonshotScore v2 · Nutrien (NTR)
StrongWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Durable growth, though the balance sheet is only middling; the market is already moving on it. Business Quality: Solid; Financial Safety: Okay; Valuation: Fair; Growth Durability: Growing; Momentum: Surging.
- quarterly revenue $6.06B (Q3 FY2026, quarter ended Sep 2026)
- EPS beat 3 of the last 8 reports
- Altman Z 1.94 · Piotroski F 8
Helping: durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 74 | Strong | |
| 73 | Strong | |
| 73 | Strong | |
| 70 | Strong | |
| 70 | Strong | |
| 70 | Strong |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $63.84 | |
| Change on the day | -2.40% | |
| 52-week range | $54.52–$85.36 | |
| Market capitalisation | $30.3B | — |
| Price / earnings (trailing) | 15.05 | |
| Shares traded on the day | 2.23M | |
| Beta (volatility vs the S&P 500) | 1.13 |
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Nutrien (NTR): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 17, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 16, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 16, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 21, 2026, except a card that shows its own read date.
What is Nutrien (NTR), and what does it report?
Short answer · as of
Nutrien is not merely a fertilizer producer. It manufactures major crop nutrients and also distributes farm inputs through an extensive network across North America, South America and Australia, with financial solutions embedded in the customer relationship.
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered).
Reported revenue therefore blends upstream fertilizer economics with retail demand for nutrients, crop protection, seed and merchandise. Consolidated margins reflect this mix, so sales growth alone cannot reveal whether production profitability or retail activity drove the result.
What do the latest results show for Nutrien (NTR)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $6.06B.
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered).
The latest quarterly statement shows higher revenue, gross profit and operating profit than the comparable period, while net income remained broadly level. Separately reported earnings cleared the revenue estimate but fell short of the earnings estimate, reinforcing that sales strength did not flow through uniformly to the bottom line.
Management expects stronger crop-nutrient gross margin per tonne to offset lower volumes and is emphasizing fertilizer fundamentals, operating execution, capital discipline and portfolio optimization. That is the stated mechanism; confirmation requires margin improvement to appear alongside resilient operating profit and cash generation.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $6.06B | $284M | $0.60 (diluted) |
| Q2 FY2026 | $10.81B | $1.21B | $2.53 (diluted) |
| Q1 FY2026 | $6.05B | $131M | $0.27 (diluted) |
| Q4 FY2025 | $5.34B | $571M | $1.18 (diluted) |
What are the financial strengths and risks for Nutrien (NTR)?
Short answer · as of
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered).
Operating cash flow rebounded sharply from an outflow, and cash plus short-term investments rose through the latest reporting sequence. Yet debt remains far larger than readily available liquidity, while the liquidity ratios indicate that the balance sheet depends on more than its most liquid assets to cover near-term obligations.
The strongest financial feature is the capacity to produce substantial cash during favorable operating periods. The corresponding risk is the severity of the intervening swings: weaker nutrient margins and volumes would leave less room for capital spending, debt service and shareholder distributions.
What should you watch next at Nutrien (NTR)?
Short answer · as of
Current published price targets run low $65.00 · high $80.00 · consensus $75.57 · median $78.00 against a quoted price of $63.84 (as of Nov 20, 2026).
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered).
Watch crop-nutrient gross margin per tonne against shipment volumes, along with progress toward the controllable potash cash-cost target. Those observations will show whether management’s margin-offset thesis is working rather than merely shifting the burden from volume to pricing and cost control.
The next earnings release should also be tested against operating cash flow after capital spending, the recent rise in cash, and the debt balance. Longer-range consensus expectations describe uneven earnings with gradual sales expansion, making cash conversion more informative than a smooth-growth narrative; continued dividend payments increase the importance of that conversion.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
How does Nutrien compare with its peers?
Short answer
Nutrien's score ranks tied for 5th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered).
Compared with a fertilizer producer, Nutrien carries direct exposure to farm-center demand for seed, crop protection, merchandise and financial solutions. Compared with a farm retailer, it owns upstream exposure to potash, nitrogen, phosphate and sulfate economics.
These activities broaden the sources of revenue but do not make them independent. Farm economics affect purchasing volumes across the retail network, while fertilizer prices, production costs and gross margin per tonne shape the profitability of the products moving through it.
| Company | Price | Market value | Score |
|---|---|---|---|
| $17.32 Nov 20, 2026 | $20.4B | 98 5-pillar Nov 18, 2026 | |
| $115.76 Nov 19, 2026 | $16.9B | 98 5-pillar Nov 18, 2026 | |
| $205.96 Nov 20, 2026 | $29.3B | 82 5-pillar Nov 18, 2026 | |
| $29.29 Nov 20, 2026 | $391M | 77 5-pillar Nov 18, 2026 | |
| Nutrien (NTR) — this page | $63.84 | $30.3B | 70 |
| $95.09 Nov 20, 2026 | $1.10B | 70 5-pillar Nov 18, 2026 | |
| $40.01 Nov 19, 2026 | $21.3B | 67 5-pillar Nov 18, 2026 | |
| $4.08 Nov 20, 2026 | $5.69B | 62 5-pillar Nov 18, 2026 | |
| $58.60 Nov 20, 2026 | $3.41B | 58 5-pillar Nov 18, 2026 | |
| $59.17 Nov 19, 2026 | $44.5B | 57 5-pillar Nov 18, 2026 | |
| $7.89 Nov 20, 2026 | $5.27B | 51 5-pillar Nov 18, 2026 | |
| $8.40 Nov 19, 2026 | $2.34B | 42 5-pillar Nov 18, 2026 | |
| $8.30 Nov 20, 2026 | $158M | 42 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $65.00 – $80.00
- Consensus target
- $75.57
- Median target
- $78.00
Consensus record · Captured .
Measured against a quoted price of $63.84 (as of Nov 20, 2026).
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 4
- Identified insiders
- 4
- Purchases
- 3
- Sales
- 0
- Other transactions
- 1
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held NTR in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0% | $0 | Sold out (was $780,769) |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
What has been published about Nutrien (NTR)?
Common Questions About NTR (Basic Materials)
Research dated 2026-09-12 (results through Q2 FY2026; Q3 FY2026 not covered); the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Why is Nutrien not just a potash producer?
Potash is part of a broader production portfolio that includes nitrogen, phosphate and sulfate. Nutrien also sells crop nutrients, protection products, seed and merchandise through farm centers and offers financial solutions to agricultural customers.
What would confirm Nutrien’s crop-nutrient margin thesis?
Higher gross margin per tonne would need to offset weaker volumes while supporting operating profit and cash generation. Management has identified that offset explicitly, making those measures the direct test.
Does Nutrien’s potash cash-cost target reduce balance-sheet risk?
Lower controllable cash costs could support fertilizer cash generation, but the target does not erase the gap between debt and liquid resources. Delivery must appear in cash flow while capital spending and debt obligations continue.
How does Nutrien’s dividend fit with its fertilizer cash cycle?
The recent per-share dividend has been stable to slightly higher, with another payment scheduled. Its durability rests on cash remaining after capital spending across reporting periods marked by pronounced operating cash-flow swings.
What is the NTR stock price today?
The last price recorded for Nutrien Ltd. (NTR), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the NTR price target?
The analyst consensus price target for Nutrien Ltd. (NTR), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-12. AI-authored analysis; source dates are listed under Sources. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 26 figures on this page — 1 from SEC filings and earnings calls, 21 from Financial Modeling Prep (FMP), 3 with no recorded source and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com